Ikarian Capital, LLC Q4 2020 Filing
Filed February 12, 2021
Portfolio Value
$2.3B
Holdings
183
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (183 positions)
| Stock | Value |
|---|---|
SRPTSAREPTA THERAPEUTICS INC | $233.9M |
BIIBBIOGEN INC | $204.7M |
MRNAMODERNA INC | $158.0M |
XBISPDR SER TR | $137.7M |
HZNPHORIZON THERAPEUTICS PUB L | $90.9M |
SPYSPDR S&P 500 ETF TR | $89.7M |
ARGXARGENX SE | $59.3M |
—ZYMEWORKS INC | $45.2M |
ARKGARK ETF TR | $41.0M |
NVV1NOVAVAX INC | $36.4M |
TCONTRACON PHARMACEUTICALS INC | $31.8M |
TCE2CELLDEX THERAPEUTICS INC NEW | $30.9M |
ARVNARVINAS INC | $28.6M |
CCXIEURCHEMOCENTRYX INC | $28.0M |
BNTXBIONTECH SE | $26.1M |
ONCBEIGENE LTD | $25.1M |
ASNDASCENDIS PHARMA A/S | $23.0M |
KALVKALVISTA PHARMACEUTICALS INC | $23.0M |
1K0IGM BIOSCIENCES INC | $22.1M |
CVACCUREVAC N V | $21.2M |
—ZOGENIX INC | $20.8M |
OCULOCULAR THERAPEUTIX INC | $20.6M |
RETAEURREATA PHARMACEUTICALS INC | $20.6M |
FGENEURFIBROGEN INC | $20.5M |
—BIOHAVEN PHARMACTL HLDG CO L | $19.1M |
BEAMBEAM THERAPEUTICS INC | $18.9M |
BMYBRISTOL-MYERS SQUIBB CO | $17.9M |
CRSPCRISPR THERAPEUTICS AG | $17.7M |
AZNASTRAZENECA PLC | $17.5M |
GILDGILEAD SCIENCES INC | $17.5M |
MORFMORPHIC HLDG INC | $17.3M |
—CURIS INC | $17.1M |
LLYLILLY ELI & CO | $16.9M |
ISIIONIS PHARMACEUTICALS INC | $16.4M |
TARAPROTARA THERAPEUTICS INC | $15.7M |
ARWRARROWHEAD PHARMACEUTICALS IN | $15.3M |
PRTAPROTHENA CORP PLC | $14.3M |
CYRXCRYOPORT INC | $14.2M |
ITCIEURINTRA CELLULAR THERAPIES INC | $14.0M |
GOSSGOSSAMER BIO INC | $13.8M |
2L9BLUEPRINT MEDICINES CORP | $13.5M |
STROSUTRO BIOPHARMA INC | $13.4M |
XLRNACCELERON PHARMA INC | $12.8M |
SG7SAGE THERAPEUTICS INC | $12.8M |
MISTMILESTONE PHARMACEUTICALS IN | $12.3M |
KRTXKARUNA THERAPEUTICS INC | $12.2M |
MRTXEURMIRATI THERAPEUTICS INC | $11.8M |
—VINCERA PHARMA INC | $11.3M |
IMVTIMMUNOVANT INC | $10.9M |
UTHUNITED THERAPEUTICS CORP DEL | $10.5M |
CMPSCOMPASS PATHWAYS PLC | $10.1M |
KURAKURA ONCOLOGY INC | $9.7M |
BDTXBLACK DIAMOND THERAPEUTICS I | $9.4M |
MRUSMERUS N V | $9.4M |
LYRALYRA THERAPEUTICS INC | $9.3M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $8.8M |
VTGNUSDVISTAGEN THERAPEUTICS INC | $8.7M |
CARAEURCARA THERAPEUTICS INC | $8.7M |
MCRB1EURSERES THERAPEUTICS INC | $8.4M |
ALLKGUSDALLAKOS INC | $8.2M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $8.0M |
CYTKCYTOKINETICS INC | $7.8M |
SCPHSCPHARMACEUTICALS INC | $7.8M |
CRDFCARDIFF ONCOLOGY INC | $7.5M |
ARDXARDELYX INC | $7.5M |
PCVXVAXCYTE INC | $7.3M |
VIRVIR BIOTECHNOLOGY INC | $7.2M |
NBPI MAB | $7.1M |
FATEFATE THERAPEUTICS INC | $7.0M |
BTAIEURBIOXCEL THERAPEUTICS INC | $6.9M |
IMTXIMMATICS N.V | $6.9M |
ALNYALNYLAM PHARMACEUTICALS INC | $6.5M |
CLVSEURCLOVIS ONCOLOGY INC | $6.2M |
ANABANAPTYSBIO INC | $6.1M |
1T7TRICIDA INC | $6.1M |
SLDBSOLID BIOSCIENCES INC | $6.0M |
CMRXEURCHIMERIX INC | $6.0M |
—STRONGBRIDGE BIOPHARMA PLC | $5.9M |
QNCXCORTEXYME INC | $5.9M |
SRRKSCHOLAR ROCK HLDG CORP | $5.7M |
AGIOAGIOS PHARMACEUTICALS INC | $5.4M |
—LIFESCI ACQUISITION II CORP | $5.4M |
SNDXSYNDAX PHARMACEUTICALS INC | $5.4M |
ASNSUSDX4 PHARMACEUTICALS INC | $5.3M |
TGTXTG THERAPEUTICS INC | $5.2M |
APLTAPPLIED THERAPEUTICS INC | $5.1M |
FULCFULCRUM THERAPEUTICS INC | $5.1M |
—SIERRA ONCOLOGY INC | $5.1M |
GTXIEURONCTERNAL THERAPEUTICS INC | $5.0M |
CCCCC4 THERAPEUTICS INC | $5.0M |
VSTMVERASTEM INC | $4.8M |
—BLUEBIRD BIO INC | $4.6M |
QDELUSDQUIDEL CORP | $4.5M |
ARCTARCTURUS THERAPEUTICS HLDGS | $4.3M |
—CHARDAN HEALTHCR ACQSTN 2 CO | $4.2M |
DMACDIAMEDICA THERAPEUTICS INC | $4.2M |
—SOCIAL CAP HEDSPIA HLDG CO I | $4.2M |
—KADMON HLDGS INC | $3.9M |
—FS DEV CORP | $3.9M |
—TCR2 THERAPEUTICS INC | $3.8M |
Page 1 of 2Next